Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Misleading advertisement on Opatanol].

A E Timmermans1

  • 1Nederlands Huisartsen Genootschap, Postbus 3231, 3502 GE Utrecht.

Nederlands Tijdschrift Voor Geneeskunde
|August 1, 2006
PubMed
Summary

Alcon

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The implementation of guidelines in The Netherlands.

Zeitschrift fur arztliche Fortbildung und Qualitatssicherung·2002
Same author

[Summary of the 'Urinary tract infections' guideline (first revision) of the Dutch College of General Practitioners].

Nederlands tijdschrift voor geneeskunde·2001
See all related articles

Area of Science:

  • Ophthalmology
  • Pharmacology

Background:

  • An Alcon advertisement promoted Opatanol (olopatadine) as the primary treatment for allergic conjunctivitis according to NHG guidelines.
  • The NHG practice guideline lists azelastine, levocabastine, and olopatadine as first-choice treatments for red eye and allergic conjunctivitis.

Discussion:

  • The advertisement's claim that Opatanol is the sole "first choice" medication is inconsistent with the NHG guideline.
  • This discrepancy raises concerns about the accuracy of pharmaceutical advertising in relation to established medical guidelines.

Key Insights:

  • The NHG guideline identifies three equally recommended first-choice antihistamines for allergic conjunctivitis.
  • Alcon's advertisement selectively highlighted olopatadine, potentially misrepresenting the guideline's recommendations.

Outlook:

  • Ensuring pharmaceutical advertisements accurately reflect medical guidelines is crucial for informed clinical decision-making.
  • Further scrutiny of advertising claims versus guideline recommendations is warranted to maintain transparency in medical practice.

Related Experiment Videos